Skip to main content
    B

    Bausch Health Companies Inc (BHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $8.43
    +0.07 (+0.90%)

    Market Cap: $3.13B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Bausch Health Companies Inc (BHC) Financials: Revenue, Profit and Cash Flow

    Updated Oct 28, 2026. Financial statements from company filings, amounts in US dollars.

    Bausch Health Companies reported revenue of $10.27B for the fiscal year ended Dec 31, 2025, up 6.7% from the year before. That year, net income was $120.00M with a net margin of 1.2%, operating cash flow was $1.40B and free cash flow was $1.00B. The quarter ended Sep 30, 2026 had revenue of $2.94B and net income of $446.00M.

    Revenue and Margins

    The operating margin was 17.7% in the fiscal year ended Dec 2025, the highest of the 9 years shown with an operating margin. Over the 9 years to Dec 2025, revenue grew from $9.67B, a compound annual rate of 0.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$10.27B+6.7%70.7%17.7%1.2%
    Dec 2024$9.63B+9.9%71.1%16.1%-0.7%
    Dec 2023$8.76B+7.8%70.8%11.0%-7.0%
    Dec 2022$8.12B-3.7%70.9%5.6%-2.6%
    Dec 2021$8.43BN/A71.6%5.3%-11.1%
    Dec 2020$0-100.0%N/AN/AN/A
    Dec 2019$8.60B+2.6%72.7%-2.4%-20.7%
    Dec 2018$8.38B-3.9%71.9%-28.4%-49.5%
    Dec 2017$8.72B-9.8%70.8%1.2%27.6%
    Dec 2016$9.67BN/A73.0%-5.9%-24.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 146.4% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$10.27B$9.63B$8.76B$8.12B$8.43B$0$8.60B$8.38B$8.72B$9.67B
    Cost of revenue$3.01B$2.78B$2.56B$2.36B$2.39B$0$2.35B$2.35B$2.55B$2.61B
    Gross profit$7.25B$6.84B$6.20B$5.76B$6.04B$0$6.25B$6.03B$6.18B$7.06B
    Research and development$629.00M$616.00M$604.00M$529.00M$465.00M$452.00M$471.00M$413.00M$361.00M$455.00M
    Operating income$1.81B$1.55B$963.00M$454.00M$450.00M$676.00M-$203.00M-$2.38B$102.00M-$566.00M
    Net income$120.00M-$72.00M-$611.00M-$212.00M-$937.00M-$559.00M-$1.78B-$4.14B$2.40B-$2.41B
    EBITDA$3.13B$2.90B$2.26B$1.94B$2.06B$2.53B$1.94B$537.00M$3.22B$2.38B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$2.94B$2.85B$2.52B$2.80B$2.68B$2.53B$2.26B$2.56B$2.51B$2.40B$2.15B$2.41B
    Gross profit$2.21B$2.08B$1.79B$2.00B$1.93B$1.77B$1.56B$1.83B$1.81B$1.68B$1.51B$1.70B
    Operating income$983.00M$740.00M-$950.00M$474.00M$619.00M$444.00M$276.00M$558.00M$318.00M$389.00M$281.00M$362.00M
    Net income$446.00M$260.00M-$1.43B-$103.00M$181.00M$128.00M-$86.00M$98.00M-$92.00M-$1.00M-$77.00M-$47.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $20.82B exceeded cash and equivalents by $19.51B. Shareholder equity was negative, at -$554.00M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$26.37B$26.52B$27.35B$25.69B$29.20B$31.20B$33.86B$32.49B$37.50B$43.53B
    Current assets$6.16B$5.77B$5.60B$4.25B$5.61B$5.34B$6.97B$4.21B$4.75B$5.08B
    Cash and equivalents$1.31B$1.18B$947.00M$564.00M$582.00M$605.00M$3.24B$721.00M$720.00M$542.00M
    Total liabilities$25.99B$26.84B$27.43B$25.43B$29.24B$30.59B$32.73B$29.68B$31.55B$40.27B
    Short-term debt$225.00M$2.67B$450.00M$432.00M$0$52.00M$1.23B$228.00M$209.00M$1.00M
    Long-term debt$20.59B$18.94B$21.94B$20.33B$22.65B$23.93B$24.66B$24.08B$25.23B$29.84B
    Shareholder equity-$554.00M-$1.28B-$1.02B-$692.00M-$106.00M$535.00M$1.06B$2.73B$5.85B$3.15B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$25.48B$24.79B$24.50B$26.32B$26.82B$27.27B$26.42B$26.52B$26.54B$26.50B$26.91B$27.35B
    Total liabilities$25.82B$25.60B$25.58B$25.94B$26.47B$27.12B$26.66B$26.84B$26.78B$26.72B$27.09B$27.43B
    Cash and equivalents$2.48B$1.82B$1.30B$1.32B$1.31B$1.73B$1.13B$1.18B$719.00M$595.00M$733.00M$947.00M
    Shareholder equity-$1.33B-$1.77B-$2.06B-$552.99M-$565.00M-$764.00M-$1.18B-$1.28B-$1.17B-$1.18B-$1.11B-$1.02B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 71.4% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$1.40B$1.60B$1.03B-$728.00M$1.43B$1.11B$1.50B$1.50B$2.29B$2.09B
    Capital expenditures$397.00M$337.00M$215.00M$218.00M$269.00M$302.00M$270.00M$157.00M$171.00M$235.00M
    Free cash flow$1.00B$1.26B$817.00M-$946.00M$1.16B$809.00M$1.23B$1.34B$2.12B$1.85B
    Dividends paidN/AN/AN/A$31.00MN/AN/AN/AN/A$18.00M$9.00M
    Investing cash flow-$595.00M-$454.00M-$2.15B-$303.00M$409.00M-$261.00M-$419.00M-$196.00M$2.89B-$125.00M
    Financing cash flow-$742.00M-$868.00M$1.48B-$474.00M-$1.51B-$2.29B$1.44B-$1.35B-$4.96B-$1.96B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$814.00M$670.00M$230.00M$495.00M$405.00M$289.00M$211.00M$601.00M$405.00M$380.00M$211.00M$390.00M
    Capital expenditures$66.00M$77.00M$109.00M$92.00M$91.00M$99.00M$115.00M$106.00M$71.00M$78.00M$82.00M$98.00M
    Free cash flow$748.00M$593.00M$121.00M$403.00M$314.00M$190.00M$96.00M$495.00M$334.00M$302.00M$129.00M$292.00M
    Last 12 quarters

    Frequently Asked Questions About BHC

    What is Bausch Health Companies' annual revenue?

    Bausch Health Companies reported revenue of $10.27B for the fiscal year ended Dec 31, 2025.

    How fast is Bausch Health Companies' revenue growing?

    Revenue was up 6.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 8.1%.

    Is Bausch Health Companies profitable?

    Yes. Bausch Health Companies reported net income of $120.00M for the fiscal year ended Dec 31, 2025, with a net margin of 1.2%.

    How much free cash flow does BHC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.40B minus capital expenditures of $397.00M produced free cash flow of $1.00B.

    How much debt does Bausch Health Companies have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $20.59B, short-term debt of $225.00M and cash and equivalents of $1.31B.